Beranda › Kanker Ovarium › Tennessee › Chattanooga
Uji klinis Kanker Ovarium di Chattanooga, TN
5 studi untuk Kanker Ovarium mencari peserta di lokasi sekitar Chattanooga (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
Menerima pesertaFase 3
- Erlanger Health, Chattanooga
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Menerima pesertaFase 3
- Erlanger Health, Inc., Chattanooga
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Menerima pesertaFase 3
- Erlanger Health, Inc., Chattanooga
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Menerima pesertaFase 1/2
- Erlanger Health, Inc, Chattanooga
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- Tennessee Oncology, PLLC, Chattanooga
Uji klinis Kanker Ovarium di kota lain
- Houston, TX89 studi
- New York City, NY69 studi
- Boston, MA61 studi
- Los Angeles, CA50 studi
- Nashville, TN49 studi
- Arlington, VA46 studi
- Philadelphia, PA44 studi
- Columbus, OH39 studi
- St. Louis, MO38 studi
- Chicago, IL36 studi
- San Antonio, TX31 studi
- Cleveland, OH30 studi
Studi lain di Chattanooga
- Kanker Paru Non-Sel Kecil11 studi
- Kanker Metastatik6 studi
- Miastenia Gravis6 studi
- Diabetes4 studi
- Penyakit Hati Steatotik4 studi
- Melanoma4 studi
- Stroke Iskemia4 studi
- Kanker Kolorektal4 studi
- Penyakit Ginjal Kronis4 studi
- Kanker Paru4 studi
- Gagal Ginjal3 studi
- Aterosklerosis3 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.